Gain Therapeutics Shares Are Trading Lower. The Company Announced Positive From the Phase 1 Study Conducted to Evaluate the Safety, Tolerability and Pharmacokinetics of GT-02287.
Gain Therapeutics Shares Are Trading Lower. The Company Announced Positive From the Phase 1 Study Conducted to Evaluate the Safety, Tolerability and Pharmacokinetics of GT-02287.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.